Risk of progression following a negative biopsy in prostate cancer active surveillance

被引：0
|
作者：
Kerri Beckmann
Aida Santaolalla
Mikio Sugimoto
Peter Carroll
Jose Rubio
Arnauld Villers
Anders Bjartell
Todd Morgan
Prokar Dasgupta
Mieke Van Hemelrijck
Oussama Elhage
机构：
[1] University of South Australia,Cancer Epidemiology and Population Health Research Group
[2] Kings College London,Translational Oncology and Urology Research
[3] Kagawa University,Faculty of Medicine
[4] University of California San Francisco,Department of Urology, UCSF—Helen Diller Comprehensive Cancer Centre
[5] Instituto Valenciano de Oncologia,Department of Urology
[6] Lille University Hospital Center,Immunology and Microbial Sciences
[7] Skane University Hospital,undefined
[8] University of Michigan and Michigan Urological Surgery Improvement Collaborative,undefined
[9] Guy’s and St Thomas’ NHS Foundation Trust,undefined
[10] King’s College London,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2023年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：403 / 409
页数：6
相关论文
共 50 条
  • [1] Risk of progression following a negative biopsy in prostate cancer active surveillance
    Beckmann, Kerri
    Santaolalla, Aida
    Sugimoto, Mikio
    Carroll, Peter
    Rubio, Jose
    Villers, Arnauld
    Bjartell, Anders
    Morgan, Todd
    Dasgupta, Prokar
    Van Hemelrijck, Mieke
    Elhage, Oussama
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) : 403 - 409
  • [2] Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer
    Salari, Keyan
    Kowitz, Jason
    Twum-Ampofo, Jeffrey
    Gusev, Andrew
    O'Shea, Aileen
    Anderson, Mark A.
    Harisinghani, Mukesh
    Kuppermann, David
    Dahl, Douglas M.
    Efstathiou, Jason A.
    Lee, Richard J.
    Blute, Michael L.
    Zietman, Anthony L.
    Feldman, Adam S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 387.e9 - 387.e16
  • [3] THE PROGNOSTIC SIGNIFICANCE OF A NEGATIVE CONFIRMATORY PROSTATE BIOPSY ON PROGRESSION FOR PATIENTS ON ACTIVE SURVEILLANCE
    Ganesan, Vishnu
    Dai, Charles
    Nyame, Yaw
    Greene, Daniel
    Almassi, Nima
    Zabell, Joseph
    Arora, Hans
    Haywood, Sam
    Crane, Alice
    Reichard, Chad
    Hettel, Daniel
    Zampini, Anna
    El-Shafei, Ahmed
    Stein, Robert
    Fareed, Khaled
    Gong, Michael
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    JOURNAL OF UROLOGY, 2016, 195 (04): : E155 - E155
  • [4] Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression
    Iremashvili, Viacheslav
    Burdick-Will, Joshua
    Soloway, Mark S.
    BJU INTERNATIONAL, 2013, 112 (01) : 39 - 44
  • [5] Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression
    Marks, Leonard S.
    BJU INTERNATIONAL, 2014, 113 (04) : E13 - E14
  • [6] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [7] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [8] DOES PERINEURAL INVASION ON INITIAL PROSTATE BIOPSY PREDICT HIGHER RISK OF PROGRESSION IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER?
    Ahmad, Ardalan E.
    Komisarenko, Maria
    Grewal, Ruby
    Timilshina, Narhari
    Hamilton, Robert
    Kulkarni, Girish
    Zlotta, Alexandre
    Fleshner, Neil
    Finelli, Antonio
    JOURNAL OF UROLOGY, 2016, 195 (04): : E156 - E156
  • [9] YOUNGER AGE IS ASSOCIATED WITH DECREASED RISK OF BIOPSY PROGRESSION DURING ACTIVE SURVEILLANCE FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER
    Leapman, Michael
    Nguyen, Hao
    Cowan, Janet
    Perez, Nanette
    Shinohara, Katsuto
    Catalona, William
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2016, 195 (04): : E56 - E56
  • [10] NEGATIVE MRI CANNOT BE USED TO AVOID BIOPSY IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Chesnut, Gregory
    Vertosick, Emily
    Benfante, Nicole
    Sjoberg, Daniel
    Eastham, James
    Fainberg, Jonathan
    Laudone, Vincent
    Lee, Taehyoung
    Scardino, Peter
    Touijer, Karim
    Vickers, Andrew
    Ehdaie, Behfar
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1013 - E1013
12345